MARIA GRAMATGES to Neoplasms
This is a "connection" page, showing publications MARIA GRAMATGES has written about Neoplasms.
Connection Strength
2.100
-
Understanding and addressing race disparities in childhood cancer outcomes. Nat Rev Cancer. 2024 Feb; 24(2):91-92.
Score: 0.299
-
Preferences for survivorship education and delivery among Latino and non-Latino childhood cancer survivors and caregivers. J Cancer Surviv. 2025 Apr; 19(2):518-525.
Score: 0.294
-
Clinician perceptions of Passport for Care, a web-based clinical decision support tool for survivorship care plan delivery. Pediatr Blood Cancer. 2023 01; 70(1):e30070.
Score: 0.275
-
Evidence for Genetic Risk Contributing to Long-Term Adverse Treatment Effects in Childhood Cancer Survivors. Annu Rev Med. 2018 01 29; 69:247-262.
Score: 0.193
-
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res. 2013 Dec; 162(6):353-63.
Score: 0.143
-
Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer. Ann Oncol. 2025 Oct; 36(10):1203-1211.
Score: 0.082
-
TTN and BAG3 in Cancer Therapy-Related Cardiomyopathy Among Long-Term Survivors of Childhood Cancer. JAMA Netw Open. 2025 06 02; 8(6):e2515793.
Score: 0.082
-
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study. Lancet Oncol. 2025 Jun; 26(6):806-816.
Score: 0.082
-
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review. JAMA Oncol. 2025 May 01; 11(5):544-553.
Score: 0.082
-
A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar. Cancer. 2025 May 01; 131(9):e35857.
Score: 0.082
-
Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer. J Clin Oncol. 2024 Jul 01; 42(19):2306-2316.
Score: 0.076
-
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO Precis Oncol. 2022 12; 6:e2200239.
Score: 0.069
-
Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention. BMC Pediatr. 2022 09 12; 22(1):541.
Score: 0.068
-
Assessing the left atrium of childhood cancer survivors. Int J Cardiovasc Imaging. 2021 Jan; 37(1):155-162.
Score: 0.059
-
Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more. Int J Cardiovasc Imaging. 2020 Oct; 36(10):1887-1895.
Score: 0.058
-
Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment. Cancer. 2019 10 15; 125(20):3623-3630.
Score: 0.054
-
Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer. J Clin Oncol. 2018 07 20; 36(21):2206-2215.
Score: 0.051
-
An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
Score: 0.050